Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis C virus research, Hepatitis B Virus Studies, and Liver Disease Diagnosis and Treatment.
Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
High microbiota reactivity of adult human intestinal IgA requires somatic mutations
Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E – The HepNet SofE pilot study
Erratum to: Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis C
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis C
Neutralisierende Antikörperaktivität von monoklonalen monoreaktiven anti-HCV-Antiköpern isoliert aus Patienten mit spontaner Viruselimination
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Neutralisierende Antikörperaktivität von monoklonalen Antiköpern gerichtet gegen das HCV Glykoprotein E2 isoliert aus Patienten mit spontaner Viruselimination